pharmaceutical company

The FDA told Amgen to test whether a quarter-dose of sotorasib worked as well as the amount on the label. It did, but the biotech is sticking to the higher dose, which earns it an extra $180,000 a year per patient.

A judge had ruled the state had the authority to enter settlements with the pharmaceutical industry that trumped lawsuits pursued by the hospital districts and school boards.

Bristol-Myers Squibb is moving its "North America Capability Center” to Hillsborough County, the Tampa Bay Times reports. The pharmaceutical giant says it…